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EFFECTIVENESS OF STEVIA REBAUDIANA WHOLE LEAF EXTRACT
AGAINST THE VARIOUS MORPHOLOGICAL FORMS OF BORRELIA
BURGDORFERI IN VITRO
P. A. S. Theophilus, M. J. Victoria, K. M. Socarras, K. R. Filush, K. Gupta, D. F. Luecke, E. Sapi*
Department of Biology and Environmental Science, University of New Haven, West Haven, CT, USA
Received: September 7, 2015; Accepted: October 26, 2015
Lyme disease is a tick-borne multisystemic disease caused by Borrelia burgdorferi. Administering antibiotics is the primary treatment for this disease; however, relapse often occurs when antibiotic treatment is discontinued. The reason for relapse remains unknown, but recent studies suggested the possibilities of the presence of antibiotic resistant Borrelia persister cells and biofilms.
In this study, we evaluated the effectiveness of whole leaf Stevia extract against B. burgdorferi spirochetes, persisters, and biofilm forms in vitro. The susceptibility of the different forms was evaluated by various quantitative techniques in addition to different microscopy methods. The effectiveness of Stevia was compared to doxycycline, cefoperazone, daptomycin, and their combinations. Our results demonstrated that Stevia had significant effect in eliminating B. burgdorferi spirochetes and persisters. Subculture experiments with Stevia and antibiotics treated cells were established for 7 and 14 days yielding, no and 10% viable cells,
respectively compared to the above-mentioned antibiotics and antibiotic combination. When Stevia and the three antibiotics were
tested against attached biofilms, Stevia significantly reduced B. burgdorferi forms. Results from this study suggest that a natural
product such as Stevia leaf extract could be considered as an effective agent against B. burgdorferi.
Keywords: Borrelia burgdorferi, biofilms, persister cells, Stevia rebaudiana, antibiotic resistance
Abbreviations: ATCC – American type culture collection; BSK-H – Barbour–Stoner–Kelly H; CefP – cefoperazone; DapM –
daptomycin; DoxC – doxycycline; EPS – extracellular polymeric substances; Log phase – logarithmic phase; PBS – phosphate
buffered saline; PI – propidium iodide; PTLDS – post-treatment Lyme disease syndrome

Introduction
Lyme disease is a leading tick-borne multisystemic disease caused by the spirochete Borrelia burgdorferi. The
bacterium is transmitted by Ixodes ticks, which could feed
on white-footed mice, rodents, deer, and birds [1, 2]. In
the United States, there are approximately 300,000 people
diagnosed with Lyme disease each year [3]. The frontline
treatment for Lyme disease is antibiotics such as doxycycline for adults and amoxicillin for children [4–8]. These
antibiotics are found effective in most cases of patients
diagnosed with Lyme disease [5–8]. However, according to the Centers for Disease Control (CDC), approximately 10–20% of the Lyme disease patients treated with
antibiotics for a recommended 2 to 4 weeks experienced
symptoms of fatigue, pain or joint and muscle aches [9].
In some patients, the symptoms even lasted for more than
6 months [9]. This condition was termed as “post-treatment Lyme disease syndrome (PTLDS)” or “chronic Lyme
disease” [9].

The mechanism associated with this condition in patients remains unclear. Though not proven, there are a couple of suggested explanations, such as the inability of the
immune system to completely clear B. burgdorferi persisters [10], or due to the presence of antigenic debris, which
might cause immunological responses [11]. Another possibility of Borrelia evading the host immune clearance after
antibiotic treatment is not well understood [12, 13].
Previous in vivo studies on mice, dogs, and nonhuman
primates have shown that B. burgdorferi could not be fully
eliminated by various antibiotics such as doxycycline, ceftriaxone, and tigecycline. Also, a recent study had demonstrated the presence of Borrelia DNA in mice following 12
months of antibiotic treatment [14]. However, the culturing
of viable organisms in Borrelia growth media could not be
achieved in these studies [14–17]. A recent study reported
the presence of Borrelia DNA from a patient with PTLDS
after antibiotic treatment [18]. Prospective clinical studies demonstrated no significant effective antibiotic therapy
and failed to show evidence of the continued presence of
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B. burgdorferi in patients with long-term symptoms [19,
20]. Other trials using prolonged intravenous ceftriaxone
treatment only improved fatigue symptoms [21]. In summary, findings suggest that conventional treatments may
not completely eliminate Borrelia persisters.
The life style of B. burgdorferi is complex as it exists in different morphological forms like the spirochetes,
spheroplast (or L-form), round bodies, and biofilms [7, 13,
22–25]. Several studies show that Borrelia can change into
round bodies when conditions become unfavorable such
as changes in temperature, high or low pH, starvation, antibiotic exposure, and/or even an attack from the immune
system [7, 23–25]. Borrelia in these defensive forms becomes dormant, immobile, and remains in this morphological state until it finds favorable conditions to return to
its spirochete form [7, 22, 24, 26]. The most effective hiding place proposed for B. burgdorferi is the recently suggested biofilm form [24]. Bacterial biofilms are organized
communities of cells enclosed in a self-produced hydrated
polymeric matrix or extracellular polymeric substances
(EPS), which is a complex mixture of polysaccharides, lipids proteins, nucleic acids, and other macromolecules [24,
27]. This unique matrix protects the underlying cells from
antimicrobial agents [24, 27]. Elimination of pathogenic
bacteria in their biofilm form is very challenging since
these sessile bacterial cells can endure the host immune
responses and are much less susceptible to antibiotics or
any other biocides than their individual planktonic counterparts [24, 27]. Biofilm resistance is based upon multiple
mechanisms, such as phenotypic changes of cells forming in the biofilm, the expression of efflux pumps, and the
presence of persister cells, which resist killing when exposed to antimicrobial agents [28, 29].
Recently, we provided evidence that B. burgdorferi is
capable of forming biofilms in vitro [24]. The aggregation
of spirochete and round body forms with several different protective layers which makes up the biofilm and extracellular polymeric substances (EPS) is proposed to be
a significant factor in antibiotic resistance [24]. It is also
reported that the biofilms have higher population of the
persister cells, which could lead to the antimicrobial resistance portrayed by these forms [24, 29].
Our previously published results on the in vitro effects
of doxycycline on B. burgdorferi showed that different
morphological forms have unique sensitivities to antimicrobial agents [7]. A recent study by J. Feng et al. showed
that doxycycline was effective in reducing the spirochetes
but not the persisters of B. burgdorferi [30, 31]. Studies
have also showed that doxycycline and amoxicillin could
eliminate the spirochetal form of B. burgdorferi, but the
dormant persisters/biofilm-like aggregates/microcolonies
were not susceptible to these antibiotics [7, 31]. Therefore, there is an urgent need to find effective agents, which
can target/eliminate all the morphological forms of Borrelia.
Natural antimicrobial agents, which have been used for
thousands of years, have been shown to be effective against
various pathogens [32]. Many in vitro and clinical stud-
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ies have demonstrated their effectiveness not only against
B. burgdorferi but also against many other pathogens
[33–38]. Stevia rebaudiana which belongs to the Asteraceae family is typically referred to as honey leaf or sweet
leaf, and due to its natural sweetness, it is used as a natural
substitute to synthetic sweetener [39–41]. The leaf extract
of Stevia possesses many phytochemicals, which include
austroinullin, β-carotene, dulcoside, nilacin, rebaudi oxides, riboflavin, steviol, stevioside, and tiamin with known
antimicrobial properties against many pathogens [40, 42,
43]. The role of these compounds is mainly to protect the
plant from microbial infection and adverse environmental
conditions [38–43]. Stevia is also well known in traditional medicine for its use in treatment of many diseases like
diabetes, high blood pressure, and weight loss [44, 45]. In
a few clinical studies, it is reported that the phytochemical
stevioside reduces blood pressure in patients experiencing mild hypertension and reduces blood glucose levels in
type 2 diabetic patients [44, 45]. It was also demonstrated
that the patients did not encounter any adverse effects from
the use of stevioside [44, 45].
Considering the effectiveness of Stevia leaf extract in
laboratory and clinical studies, we evaluated the antimicrobial potential of Stevia (whole leaf extracts) against the
Lyme disease causing pathogen, B. burgdorferi, in a goal
to eliminate all the different morphological forms in vitro.
To effectively evaluate the whole Stevia leaf extract, we
compared the antimicrobial effect of Stevia with antibiotics (doxycycline, cefoperazone, daptomycin) and their
combination, which were recently found effective against
Borrelia persisters.

Materials and methods
Bacterial culture conditions and media requirements
Low passage isolates (≤ 8) of B. burgdorferi strain B31
were obtained from the American Type Culture Collection (ATCC 35210) and were cultured in Barbour–
Stoner–Kelly H (BSK-H) media (Sigma, St Louis, MO)
supplemented with 6% rabbit serum (Pel-Freez®, Rogers,
AR). The antibiotic free cultures were maintained in sterile 15 ml glass tubes and incubated at 33 °C with 5% CO2.
For logarithmic (log) phase, 1 × 105 cells/ml were seeded
in glass tubes and allowed to grow for 5 days. The effectiveness of the antimicrobial agents on the logarithmic
phase was tested by inoculating 1 × 105 spirochetes/ml
from the five-day grown culture (containing only spirochetes) in 90 μl of BSK-H media in 96-well tissue culture
plates (BD Falcon, Franklin Lakes, NJ), which were incubated for 5 days at 33 °C with 5% CO2. The cells were
treated with antimicrobial agents for 3 days after a twoday incubation period. Likewise, for the stationary phase,
1 × 105 cells/ml were seeded in glass tubes and allowed to
grow for 7 days. The effectiveness of the antimicrobial
agents was tested by inoculating 1× 106 spirochetes/ml in
90 μl of BSK-H media in a 96-well tissue culture plate,
European Journal of Microbiology and Immunology

270

P. A. S. Theophilus et al.

which was incubated for 8 days at 33 °C with 5% CO2.
The persister cells in stationary phase were treated with
antimicrobial agents for 3 days after 5 days of incubation.
Biofilms were generated by inoculating 5 × 106 cells/ml
of Borrelia spirochetes in 1 ml of BSK-H media in fourwell chamber slides (Thermo Scientific, Waltham, MA) or
plastic/collagen-coated tissue culture 48-well plates (BD
Falcon), which were incubated for 7 days at 33 °C with
5% CO2. The treatment regime for the biofilms was the
same as that for the stationary phase.
Compounds and antibiotic preparation
Different Stevia extracts manufactured by Nutramedix®,
Now®, Sweet leaf®, and Truvia® were purchased from
health food stores in the USA and were labeled randomly
as Stevia A, B, C, and D. The extracts A, B, and C were
formulated by standard alcohol extraction method whereas extract D was purchased in a powder form dissolved
in distilled water. Stevioside (Sigma) was prepared in
0.001% DMSO and further diluted in 1× phosphate buffered saline (PBS, 0.1 M, pH 7.4 from Sigma). The antibiotics doxycycline, cefoperazone, and daptomycin (Sigma)
at a concentration of 10 μg/ml were prepared in PBS. All
antimicrobial agents were sterilized using a 0.2-μm filter
unit (EMD Millipore, Billerica, MA). The antibiotic solutions were aliquoted and stored at minus 20 °C.
Determining the protein concentrations
of the antimicrobial agents
Since the concentration of the antimicrobial components
in the Stevia extracts A, B, C, and D were unknown, the
concentration units used initially involved the use of part
of solute per 50 parts of solution (1:50 dilution). The protein content of antimicrobial agents was determined by
Bradford assay (Sigma) using serial dilutions of 2 mg/ml
of bovine serum albumin stock (Sigma) in PBS pH 7.4 as
a standard. Bradford reagent was added to the antimicrobial agents according to the manufacturer’s instructions
and incubated for 10 min at room temperature with gentle
shaking. The absorbance was measured at 595 nm using a
BioTek spectrophotometer.
In vitro antimicrobial susceptibility testing
of B. burgdorferi
The effective antibiotics and the antibiotic combination
identified [30] were tested to compare and evaluate the
effectiveness of Stevia on B. burgdorferi. As a positive
control, doxycycline (10 μg/ml) was used. As a negative
control, 1× PBS at pH 7.4 was used to dissolve antibiotics and 25% alcohol (Fisher Scientific, Pittsburg, PA) was
used since all the Stevia extract contained the same alcohol
diluent.
European Journal of Microbiology and Immunology

SYBR Green I/PI assay
To evaluate live and dead cells, standard SYBR Green I/
propidium iodide assay (SYBR Green I/PI) was performed as previously described [30, 31, 46, 47]. To
1 ml of sterilized distilled water, 10 μl of SYBR Green I
(10,000× stock, Invitrogen, Grand Island, NY) and 30 μl
of propidium iodide (Thermo Scientific) were briefly
mixed. The staining mixture (10 μl) was added to all the
wells containing B. burgdorferi and was incubated in the
dark for 15 min. The plates were measured using a fluorescent reader (BioTek FLx800) by setting the excitation
wavelength at 485 nm and the absorbance wavelength
at 535 nm (green emission) and 635 nm (red emission).
The standard equation was determined from 1 × 106 cells
(logarithmic phase), 5 × 106 cells (stationary phase), and
1 × 107 cells (7 days and 14 days subculture). A live and
dead population was prepared. For the dead cell population, the cells were killed by adding 300 μl of 70% isopropyl alcohol (Fisher Scientific). B. burgdorferi suspensions at different ratios of live/dead cells (0:10, 2:8, 5:5,
8:2, 10:0) were added to the wells of the 96-well plate
accordingly. The staining mixture was added to each of
the five samples, and the plate was read as above. Using least square fitting analysis, the regression equation
was calculated between the percentage of live bacteria
and green/red fluorescence ratios. The regression equation was used to calculate the percentage of live cells in
each sample of the screening plate. Also, images of the
treated sample were taken using fluorescent microscopy
(Leica DM2500).
Total viable counts of B. burgdorferi
As a confirmation test, the SYBR Green/PI stained cultures were assessed for cell growth by directly counting
live and dead bacteria using a bacterial counting chamber
(Hausser Scientific, Horsham, PA) and fluorescent microscopy (Leica DM2500). As above, using least square fitting
analysis, the regression equation was calculated between
the percentage of live bacteria and green/red fluorescence
ratios. The regression equation was used to calculate the
percentage of live cells in each sample.
Long-term subculture experiments to assess viability
of treated B. burgdorferi stationary phase culture
To assess if the treated stationary phase cultures can regrow in fresh media, 96-well plates were filled with 100
μl of fresh BSK-H media. From the treated stationary
phase cultures, 1:75 dilution of treated stationary phase
culture was added to a sterile 96-well plate (BD Falcon)
containing 100 μl of fresh BSK-H media and incubated
for 7 days and 14 days without antimicrobial treatment.
Following incubation, the viability was assessed using the
SYBR Green I/PI assay and direct counting method.
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Crystal violet biofilm assay

Results

The efficacy of the antimicrobial agents on biofilms was
determined by quantifying the total biomass using crystal
violet staining. Following incubation, the media was slowly discarded leaving behind the attached biofilms on the
surface of the plate. The attached biofilms were collected
by adding 500 μl of PBS (0.1 M, pH 7.4) to the samples. All
centrifugation steps were performed at 12,000 × g at room
temperature. Biofilms were pelleted for 5 min, and the supernatant was discarded. A volume of 50 μl (0.01%) crystal
violet (Sigma) was added to the pellet, and the mixture was
incubated for 15 min at room temperature. The unbound
stain was removed by pelleting the biofilms for 5 min and
by discarding the supernatant. The pellet was washed with
200 μl PBS and again pelleted for 5 min. The supernatant
was discarded in addition to adding 200 μl of 10% acetic
acid (Sigma) to the pellet to release and dissolve the stain.
The samples were then incubated at room temperature for
15 min. Biofilms were pelleted for 5 min prior to extracting
the crystal violet stain from the biofilms, which were transferred to a 96-well plate, and absorbance was measured at
595 nm using a BioTek spectrophotometer.

In this study, we compared and evaluated the antimicrobial
effect of S. rebaudiana whole leaf extract along with the
antibiotics doxycycline, cefoperazone, and daptomycin
on the different morphological forms (spirochetes, round
bodies, and biofilms) of B. burgdorferi. We used a recently
developed high throughput screening method [30, 31, 46]
to assess the viability of the log phase and stationary phase
B. burgdorferi after the different antimicrobial treatments
(quantitatively and qualitatively) in conjunction with direct counting methods as described in our previous publication [7]. Similar to recent studies, we have evaluated
both the log phase B. burgdorferi cultures which consist of
individual spirochetes, the stationary phase cultures which
consist of the persister cells, and the most resistant form
of B. burgdorferi, the attached surface biofilms. Finally,
atomic force microscopy was used in conjunction with the
aforementioned methods, to visualize changes in the morphology in attached biofilms before and after antibiotic
treatments.
Preliminary screening of different Stevia extracts

Live/dead bacterial staining technique
To visualize the antimicrobial sensitivity of biofilms, the
treated biofilms were stained using SYBR Green (Invitrogen) and propidium iodide (Thermo Scientific). The stains
were prepared as per the SYBR Green I/PI assay protocol. To each well of the chamber slide, 5 μl of the staining mixture was added and allowed to incubate in the dark
for 15 min. The media was removed carefully not to disturb the attached biofilm. Slides were cover slipped, and
images were taken using fluorescent microscopy (Leica
DM2500).

Here, we first evaluated four different commercially obtained Stevia extracts (3 alcohol extracts and one extract
in powder form) and the purified Stevioside on B. burgdorferi to find the most effective agent for further studies
using the SYBR Green/PI assay. The protein concentration of the four Stevia leaf extracts was determined by a
standard Bradford assay and ranged from 1.2 μg/ml to
1.9 μg/ml. Stevioside was tested at concentration from 100
to 1000 μg/ml, concentration as suggested from a previous
study [42].

Atomic force microscopy
To visualize the morphology of the antimicrobial treated
biofilms grown on glass chamber slides (Thermo Scientific), the media was carefully removed without disturbing
the biofilm. Contact mode AFM imaging in air was performed on a Nanosurf Easyscan 2 AFM (Nanosurf) using
SHOCONG probes (APPNANO). Images were processed
using Gwyddion software (Nečas and Klapetek).
Statistical analysis
Statistical analysis was performed using two-tailed
Student’s t-test (Microsoft Excel, Redmond, WA) and
graphed using GraphPad Prism® 6.0 (La Jolla, CA). All
experiments were performed a minimum of three separate
times with at least three samples per experiment. Data was
normalized to the control and presented as the mean ± SD.

Fig. 1. Preliminary screening of four different extracts of Stevia
and Stevioside on the stationary phase of B. burgdorferi after a
three-day treatment using the SYBR Green/PI assay. n = 3 ± SD,
*
p ≤ 0.05, **p ≤ 0.01 compared to the control
European Journal of Microbiology and Immunology
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For the prescreening experiments, we have pretested
all agents on the log and stationary phase Borrelia cultures at different concentrations using the SYBR Green/
PI assay. Our results showed that Stevia A, Stevia B, and
Stevia C alcohol extracted agents had significant effects
on the viability of Borrelia cells, but Stevia D, powdered
form, and Stevioside did not show any significant effect
on both the log phase and the stationary phase cells. Figure 1 shows a representative experiment demonstrating

that the alcohol extracted based Stevia agents (A, B, C)
were the most effective against the Borrelia persisters,
while the powder form of Stevia leaf extract (D) and
Stevioside had no effect on those resistant cells. Furthermore, Stevia A showed the most promising effect in
all experiments, and therefore, Stevia A was used in the
subsequent experiments on the different morphological
forms of B. burgdorferi.

Fig. 2. Susceptibility of log phase (5 days) and stationary phase (8 days) Borrelia burgdorferi to antimicrobial agents after a three-day
treatment determined by (A) SYBR Green I/PI assay, (B) direct counting of live and dead cells stained using a mixture of SYBR Green
I and propidium iodide using fluorescent microscopy. (C) Representative live/dead images of log and stationary phase B. burgdorferi
to antimicrobial agents taken at 200× magnification (Scale bar − 100 μm). Doxycycline (DoxC) was used as a positive control. 1×
PBS and 25% alcohol were used as negative controls, respectively. All antibiotics individually as well as in combination were used
at a concentration of 10 μg/ml. Stevia A was used at a concentration of 1.2 μg/ml. n = 3 ± SD, *p ≤ 0.05, **p ≤ 0.01 compared to the
control. n = 3 ± SD, +p ≤ 0.05, ++p ≤ 0.01 (doxycycline compared to Stevia A). n = 3 ± SD, *p ≤ 0.05, **p ≤ 0.01 (doxycycline compared
to Stevia A). Abbreviations: doxycycline – DoxC, cefoperazone – CefP, daptomycin – DapM
European Journal of Microbiology and Immunology
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Stevia as a potential agent in eliminating different forms
of B. burgdorferi
To compare and evaluate the effectiveness of Stevia on
B. burgdorferi, recently identified potential antibiotics and
their combinations were tested along with Stevia A extract
using the SYBR Green I/PI assay on both log and stationary phase cultures. Appropriate amounts of 1× PBS pH 7.4
and 25% alcohol were used as negative controls.
According to the SYBR Green I/PI assay and the live/
dead images, treatment with 1× PBS or 25% alcohol did
not significantly reduce the viability of the spirochete rich
log phase culture and persisters rich stationary cultures
compared to the control (Fig. 2A, and 2C: panels i–iii and
ix–xi). Figure 2C: panels i–iii and ix–xi demonstrated that
the control B31 culture, 1× sterile PBS, and 25% alcohol
treated cultures comprised only live cells (green).
In the next set of experiments, we tested several previously reported effective antibiotics on B. burgdorferi such
as doxycycline, cefoperazone, and daptomycin individually and in combinations [30, 31].
Doxycycline, as reported earlier [30, 31] was significantly able to reduce the viability of log phase B. burgdorferi by ~99% compared to the control (Fig. 2A, and
2C: panel iv). However, doxycycline treatment had no significant effect on the cells in the stationary phase cultures
as observed by increasing proportion of viable cells after
antibiotic exposure compared to the control (Fig. 2A, and
2C: panel xii).
Cefoperazone at 10 μg/ml, which was previously identified as one of the drugs with high activity against Borrelia persisters [30, 31], significantly reduced the log phase
viability of Borrelia by ~99% (Fig. 2A, and 2C: panel v)
but, in contrast, only reduced the stationary phase viability
by ~18% compared to the control (Fig. 2A). A large population of live round body forms and a mixture of live and
dead spirochetal cells were observed in stationary phase
culture (Fig. 2C: panel xiii).
Daptomycin, one of the other drugs previously identified with potent activity against Borrelia persisters [30, 31],
also significantly reduced the live spirochetal enriched log
phase culture by ~23%, but it was less sensitive in reducing viable cells in the stationary phase (~16% reduction
of live cells) compared to the control (Fig. 2A). Images
demonstrated that cells treated with daptomycin, both log
and stationary phase show more live cells than dead cells
(Fig. 2C: panels vi and xiv) compared to control.
A recent study reported that the combination of doxycycline, cefoperazone, and daptomycin successfully eliminated both spirochetes and persisters [30]. Our data from
this study also confirmed the effectiveness of these threeantibiotic combination on B. burgdorferi by significantly
eliminating the live log phase spirochetes (100% effect)
and also significantly reduced the viability of the stationary phase culture by ~86% (Fig. 2A, and 2C: panels vii
and xv).
In these experiments, we also tested potential antimicrobial agent Stevia A as an individual agent and com-
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pared its effectiveness to the individual antibiotics and the
three-antibiotic combination. In Fig. 2A, and 2C: panels
viii and xvi, Stevia A significantly eliminated the log phase
spirochetes and the stationary phase persisters compared
to the control (100% effect for both). The log phase and
the stationary phase culture treated with Stevia A had only
dead cells (Fig. 2C: panels viii and xvi).
In Fig. 2A, the effectiveness of doxycycline and the
three-antibiotic combination was compared with Stevia A.
A significant elimination (p value ≤ 0.01) in the persisters
was found with Stevia A compared to doxycycline.
Direct counting confirms the effectiveness of Stevia A
on the log phase spirochetes and stationary phase rich
persisters
To further validate the effectiveness of the antimicrobial
agents evaluated using the SYBR Green I/PI assay, direct
counting was performed as described previously [7, 31].
According to the direct counting method, the negative controls, 1× sterile PBS and 25% alcohol, did not
significantly reduce the number of viable cells in both
the log phase and stationary phase compared to the control (Fig. 2B). While doxycycline significantly reduced
the log phase viability of Borrelia by ~98%, it did not reduce the stationary phase viability compared to the control
(Fig. 2B). Cefoperazone was also significantly able to reduce the viability of log phase Borrelia by ~99% (Fig. 2B),
whereas cefoperazone in the stationary phase cultures was
less effective (~32% reduction) in eliminating the persisters as observed by increasing proportion of remaining viable cells after antibiotic exposure compared to the control
(Fig. 2B, and 2C: panel xiii). Daptomycin, significantly
reduced the live spirochetal enriched log phase culture by
~44% and also significantly reduced the stationary phase
by ~42% compared to the control (Fig. 2B). The threeantibiotic combination of doxycycline, cefoperazone, and
daptomycin significantly eliminated the log phase culture
and also the stationary phase culture by ~84% compared to
the control (Fig. 2B). The potent antimicrobial agent, Stevia A, significantly eliminated the log phase spirochetes
and significantly reduced the persisters by ~94% (Fig. 2B).
In Fig. 2B, the effectiveness of doxycycline and the
three-antibiotic combinations was compared with Stevia A. A significant reduction (p value ≤ 0.01) in the persisters was found with Stevia A compared to doxycycline.
Effectiveness of Stevia A after a 7-day and 14-day
subculture of antimicrobial treated B. burgdorferi
In the above-mentioned experiments, we have demonstrated the effectiveness of Stevia A on both spirochetes
and the persisters of Borrelia and provided data that its
significant effect is very comparable to the three-antibiotic
combination reported previously [31]. To confirm the effectiveness of Stevia on the persisters, we performed a
European Journal of Microbiology and Immunology
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7-day and 14-day subculture experiment in fresh BSK-H
medium to observe if the persisters, if any, still left in the
culture, could regrow in fresh medium assayed by the
SYBR green I/PI and the direct counting methods.
As expected, the treatment with negative controls, 1×
PBS and 25% alcohol, was able to successfully repopulate
the media with predominating green live cells similar to
the untreated B31 control after a 7- and 14-day subculture (Fig. 3A, and 3C: panels i–iii and ix–xi). The threeantibiotic combination and cefoperazone resulted in 5–7%

of viable cells after a 7-day subculture, but there was a
significant 14% increase in the number of viable cells
treated with cefoperazone and a 11% increase in viable
cells treated with the three-antibiotic combination after a
14-day subculture (Fig. 3A, and 3C: panels v, vii, xiii, and
xv). There was a significant 13% and 53% increase in viable cells from the sample treated with doxycycline after
a 7-day subculture and a 14-day subculture, respectively
(Fig. 3A, and 3C: panels iv and xii). The treatment with
daptomycin, however, produced predominating live cells

Fig. 3. A 7-day and 14-day subculture of 8-day-old Borrelia burgdorferi stationary phase culture treated with antimicrobial agents
determined by (A) SYBR Green I/PI assay and direct counting of live and dead cells stained using a mixture of SYBR Green I and
propidium iodide using fluorescent microscopy. (B) Representative live/dead images of a 7-day-old subculture on stationary phase
B. burgdorferi treated with antimicrobial agents taken at 200× magnification (Scale bar − 100 μm). Doxycycline (DoxC) was used as
a positive control. 1× PBS and 25% alcohol were used as negative controls respectively. n = 3 ± SD, *p ≤ 0.05, **p ≤ 0.01 compared
to the control. n = 3 ± SD, +p ≤ 0.05, ++p ≤ 0.01 (doxycycline compared to Stevia A). n = 3 ± SD, *p ≤ 0.05, **p ≤ 0.01 (doxycycline
compared to Stevia A). Abbreviations: doxycycline – DoxC, cefoperazone – CefP, daptomycin – DapM
European Journal of Microbiology and Immunology
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after a 7-day and 14-day subculture (Fig. 3A, and 3C: panels vi and xiv). Interestingly, there was no regrowth with
the sample treated with Stevia A as there were only dead
cells (100% elimination) after a 7-day subculture, and only
a 10% increase in viable cells was observed after a subculture for 14 days (Fig. 3A, and 3C: panels viii and xvi).
In Fig. 3A, the effectiveness of doxycycline and the
three-antibiotic combination after a 7-day and a 14-day
subculture was compared with Stevia A. A significant reduction (p value ≤ 0.05) in the regrowth of Borrelia was
found with Stevia A compared to doxycycline after a 14day subculture.
Direct microscopic counting confirmed the SYBR
Green I/PI assay and showed that drug-free controls and
the negative controls (1× PBS and 25% alcohol) grew well
in the 7-day and 14-day subcultures (Fig. 3B). Samples
treated with doxycycline, cefoperazone, and the three-antibiotic combination produced ~2% viable cells after 7 days
(Fig. 3B). Cefoperazone and the three-antibiotic combination produced ~1% viable cells after a 14-day subculture
(Fig. 3B). However, there was an increase in viable cells
by 68% treated with doxycycline after a 14-day subculture
(Fig. 3B). Daptomycin treated cells were able to recover
better than the other antibiotic counterparts with regrowth
similar to the drug-free control in the 7- and 14-day subcultures (Fig. 3B). Samples treated with Stevia A after a
7-day subculture showed no signs of regrowth, and only
1% of viable cells were observed after a 14-day subculture
(Fig. 3B).
In Fig. 3B, the effectiveness of doxycycline and the
three-antibiotic combination in the direct counting method, after a 7-day and a 14-day subculture, was compared
with Stevia A. Significant reduction (p value ≤ 0.01) in the
regrowth of Borrelia was found with Stevia A compared to
doxycycline after a 14-day subculture.
Stevia A significantly reduced Borrelia biofilms grown
on plastic and collagen surfaces
Multiple morphological forms of B. burgdorferi, i.e, spirochetal form, round bodies, and biofilms have been observed to have different antimicrobial susceptibilities [7].
In our previous publication, we characterized the antibiotics sensitivity of the biofilm form of B. burgdorferi and
found that it is the most resistant form [7]. In this study, to
evaluate the effect of antimicrobial agents on Borrelia biofilms grown on plastic and collagen surfaces, we stained
the antimicrobial treated biofilms with crystal violet to
quantify the effectiveness of the different antimicrobial
agents.
Biofilms grown on plastic surface and treated with
negative controls, 1× PBS or 25% alcohol, did not show
reduction in the biofilm masses compared to the untreated
biofilm control (Fig. 4). Biofilms treated with doxycycline, cefoperazone, daptomycin, and the three-antibiotic
combination showed significant increase in Borrelia biofilm mass compared to the drug-free control (Fig. 4). The
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Fig. 4. Susceptibility of Borrelia burgdorferi biofilms grown
on plastic and collagen-coated surface to antimicrobial agents
after a three-day treatment determined by crystal violet assay.
Doxycycline (DoxC) was used as a positive control. 1× PBS and
25% alcohol were used as negative controls, respectively. All
antibiotics individually as well as in combination were used at a
concentration of 10 μg/ml. Stevia A was used at a concentration
of 1.2 μg/ml. n = 3 ± SD, *p ≤ 0.05, **p ≤ 0.01 compared to the
control. n = 3 ± SD, +p ≤ 0.05, ++p ≤ 0.01 (doxycycline compared
to Stevia A). n = 3 ± SD, •p ≤ 0.05, • •p ≤ 0.01 (doxycycline
compared to Stevia A). Abbreviations: doxycycline – DoxC,
cefoperazone – CefP, daptomycin – DapM

treatment with Stevia A, however, significantly reduced
Borrelia biofilms on plastic by ~40% compared to the
control (Fig. 4).
Biofilms grown on collagen-coated surface show that
the treatment with negative control, 1× PBS or 25% alcohol, did not show reduction in the biofilm masses compared to the control (Fig. 4). Treatments with doxycycline
and daptomycin did not have any significant effect on
Borrelia biofilm mass (Fig. 4). There was an increase in
Borrelia biofilms grown on collagen when treated with
cefoperazone, and in contrast, there was a 10% reduction
observed in these biofilms when treated with the threeantibiotic combination compared to the control (Fig. 4).
In addition, biofilms treated with Stevia A also showed
significant reduction on collagen by ~34% compared to
the control (Fig. 4). In order to assess the effectiveness of
doxycycline and the three-antibiotic combination to Stevia
A, the results in Fig. 4 showed that there was a significant
reduction in the total Borrelia biomass grown on plastic
and collagen surfaces by Stevia A compared to doxycycline and the three-antibiotic combination (p value ≤ 0.01).
Stevia A decreases viability in attached Borrelia biofilms
In order to directly observe the viability of attached biofilms after antimicrobial treatment, we stained the treated
biofilms using a mixture of SYBR Green I and propidium
iodide (live/dead stains). The Borrelia biofilms treated
with 1× PBS and 25% alcohol were large and compact,
mostly staining green, depicting that the biofilm was live
European Journal of Microbiology and Immunology
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Fig. 5. Representative live/dead images of Borrelia biofilms treated with different antimicrobial agents followed by staining with
SYBR Green I and PI dye mixture taken at 200× magnification. Doxycycline (DoxC) was used as a positive control. 1× sterile PBS
and 25% alcohol were used as negative controls, respectively. All antibiotics individually as well as in combination were used at a
concentration of 10 μg/ml. Stevia A was used at a concentration of 1.2 μg/ml. Scale bar −100 μm. Abbreviations: doxycycline – DoxC,
cefoperazone – CefP, daptomycin – DapM

(Fig. 5: panels ii and iii). The biofilms treated with cefoperazone were significantly smaller compared to the biofilms treated with doxycycline, and both were green with
small red spots indicating that they were alive (Fig. 5: panels iv and v). The biofilms treated with daptomycin were
large and compact and stained mostly green with live cells

(Fig. 5: panel vi), whereas the biofilms treated with the
antibiotic combination were made up with a mixture of
live and dead cells with live cells predominating (Fig. 5:
panel vii). Borrelia biofilm treatment with Stevia A stained
predominantly red, depicting that the biofilm had mainly
dead spirochetes and round bodies (Fig. 5: panel viii). The

Fig. 6. Representative atomic force microscopy images showing the ultrastructural details of Borrelia biofilm before and after treatment
with antimicrobial agents. The preparations of B. burgdorferi strain B31 biofilms on chamber slides are described in Materials and
methods section. All biofilms were scanned at 0.4 Hz using contact mode and the individual Z ranges (height) are indicated next to
each panel by means of a scale. The images were scanned using the Nanosurf Easyscan 2 software, and the images were processed
using Gwyddion software. All antibiotics individually as well as in combination were used at a concentration of 10 μg/ml. Stevia A
was used at a concentration of 1.2 μg/ml. Abbreviations: doxycycline – DoxC, cefoperazone – CefP, Daptomycin – DapM
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morphology of the Stevia A treated biofilm was small and
loosely packed compared to the biofilms treated with antibiotics (Fig. 5: panel viii).
AFM analysis shows loose morphology with biofilms
treated with Stevia A
The atomic force microscopic images, which are 3D rendered and digitally colored for improved visualization,
show the ultra structural features in the biofilms before
and after treatment with antimicrobial agents. The red
color shows the highest peak in the biofilms, which mainly
indicates the potential presence of biofilm EPS matrix. The
drug-free control had a very compact and rigid structure
with notable EPS buildup (Fig. 6: panel i). The biofilms
treated with doxycycline, cefoperazone, daptomycin, and
the three-antibiotic combination were similar to the control having compact structure with more potential layers
of EPS (Fig. 6: panels ii–v). Interestingly, Stevia treated
biofilms have a very loose structure with the EPS layer
almost not formed (Fig. 6: panel vi).

Discussion
In this study, we evaluated the antimicrobial potential
of whole leaf Stevia extracts against the Lyme disease
causing pathogen, B. burgdorferi. We compared the
antimicrobial effect of Stevia with antibiotics (doxycycline, cefoperazone, daptomycin) and their combination,
which were recently found effective against Borrelia
persisters [31]. For this study, we have chosen to utilize
a novel quantitative method developed by J. Feng et al.
combined with our previously reported direct counting
method [7, 30, 31, 46]. Findings from this study show
that Stevia whole leaf extract, as an individual agent,
was effective against all known morphological forms of
B. burgdorferi.
In the preliminary screening experiment using different extracts of Stevia, we demonstrated a significant variation in the effectiveness of the alcohol extracts of Stevia
(Stevia A, Stevia B, and Stevia C) on Borrelia persisters
compared to the powder form of Stevia (Stevia D) and
purified Stevioside which did not show any effect (Fig. 1).
We also found that one of the Stevia compounds, Stevia
A, significantly eliminated Borrelia persisters compared
to other Stevia extracts (Fig. 1). This might be explained
by the reported variations observed in the different phytochemical concentrations of different Stevia extracts,
which resulted from the growing conditions and agricultural practices followed [47, 48]. Since Stevia A was
effective in eliminating Borrelia persisters, Stevia A was
chosen for further investigating the effectiveness on the
different morphological forms of B. burgdorferi.
In the next set of experiments, we compared the effectiveness of Stevia A to the antibiotics and the threeantibiotic combinations found effective in recent reports
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by J. Feng et al., [31] first to Borrelia spirochetes and then
the persisters using the quantitative method developed by
J. Feng et al. and E. Sapi et al. We observed that Stevia
A, even at a lower concentration (1.2 μg/ml), could significantly eliminate the viability of early log phase and
stationary cultures of B. burgdorferi using the SYBR
Green I/PI method (Fig. 2A, and 2C: panels viii and xvi)
which was also confirmed using the direct counting method (Fig. 2B, and 2C: panels viii and xvi). According to
a report by J. Feng et al. (2015), daptomycin and cefoperazone, although effective against Borrelia persisters,
could not completely eliminate the microcolony form of
B. burgdorferi [30]. It was also observed from previous
in vivo and in vitro studies that doxycycline was effective in eliminating the spirochetes but not the persisters
of Borrelia [7, 16, 17, 30, 31]. However, J. Feng et al.
also showed that the three-antibiotic combination (doxycycline, cefoperazone, and daptomycin) was very potent
in eliminating the stationary phase rich persisters of Borrelia [30]. In this study, we provided evidence that Stevia
A, as an individual agent, was capable of eliminating the
spirochetes and the persisters of Borrelia similar to the
reported three-drug combination treatment. Our data also
showed that the antibiotics in combination on the persisters of Borrelia was indeed consistent with the previous
study [30]; this result further confirms the effectiveness
of Stevia A.
In our previous studies, we characterized the biofilm
form of B. burgdorferi in vitro, and showed that it represents the most antibiotic resistant form [24]. It is also
reported that biofilms attached to a surface are protected
from antibiotics or other antimicrobial agents [28, 29]. In
this study, we also evaluated the effect of all antimicrobial
agents on attached Borrelia biofilms. Our results showed
that Stevia A is very effective, in reducing attached Borrelia biofilm mass on both plastic and collagen coated surfaces by ~40% (Fig. 4) whereas the individual antibiotics
actually induced the size of the biofilm mass (Fig. 4).
It was previously reported that certain antibiotics
could indeed promote bacterial biofilm formation [49].
One potential explanation is that cells in biofilms are
capable of protecting themselves from unfavorable antibiotic environment [24, 28] by developing several defensive mechanisms such as poor antibiotic penetration,
phenotypic changes of cells forming in the biofilm, the
expression of efflux pumps, and the presence of persister
cells, which resist dying when exposed to antimicrobial
agents [28, 29]. Persisters are a subpopulation of highly
resistant cells, which are found among the normal cell
population, and they are dormant and highly protected
[28]. Studies show that small fraction of cells in biofilms
were unaffected after prolonged antibiotic treatment [29,
53].
The obvious question on how Stevia could affect the
highly resistant Borrelia biofilm warrants further investigation. In a study using a sugar alcohol, it was reported
that xylitol acts as an antiplaque agent by disrupting the
formation of biofilms in the oral cavity [54]. In another
European Journal of Microbiology and Immunology
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study, they showed that xylitol affects the production of
adhesive polysaccharides of Streptococcus mutans [55].
It was previously shown that sugars prime the uptake of
antibiotics in Staphylococcus aureus and Escherichia coli
[56]. Based on these previous findings, we hypothesize
that Stevia could act as a sugar derivative, which might
prime the uptake of the phytochemicals responsible for
the antimicrobial effect and, thereby, disrupt the biofilm
structure. In support to our hypothesis, we also showed
that the ultrastructure of Stevia A-treated biofilm has very
loose morphology with large shallow pits compared to the
compact structure of biofilms treated with doxycycline,
cefoperazone, daptomycin, and the antibiotic combination (Fig. 6: panels ii–vi).
To further confirm the effectiveness of Stevia, we performed long-term subculture experiments using the antimicrobial treated, stationary phase predominated with
Borrelia persisters by transferring a population of the
treated cells into fresh culture medium to observe if viable cells can regrow after a 7-day and a 14-day period in
the absence of antimicrobial agent. The natural antimicrobial agent (Stevia A) was shown to be effective with no
regrowth of viable cells after a 7-day subculture and with
only 10% increase in viable cells after a 14-day subculture. The effects of the three-antibiotic combination, when
compared to Stevia A, regrew with 5% and 11% of viable
cells as detected using the SYBR Green I/PI method and
confirmed by fluorescent microscopy (Fig. 3A, and 3B:
panels vii, viii, xv, and xvi). We also observed that Borrelia treated with doxycycline and cefoperazone, which
did not show any significant effect against the persisters
(Fig. 2A, 2B, and 2C: panels xii and xiii), recovering with
only 13% and 6% viable cells after a 7-day subculture
(Fig. 3A, and 3C: panels iv and v). One possible explanation for this phenomenon could be that antibiotic sensitivity might have been restored when bacteria are dispersed
from a biofilm during favorable conditions [28].
Stevia leaf extract is a widely used sugar substitute
[39–41, 57]; however, recent studies show that one of
the major glycosides, stevioside, could have antimicrobial effect against Bacillus cereus, Bacillus subtilis,
Klebsiella pneumoniae, and Pseudomonas aeruginosa
[42]. These antimicrobial studies used a high concentration of purified stevioside, and in our study, we achieved
similar antimicrobial effect against Borrelia by using a
lower concentration of the whole leaf extract. Our data
with purified Stevioside did not show any significant antimicrobial effect on Borrelia spirochetes and persisters
compared to the whole leaf extracts of Stevia (Fig. 1).
This finding suggests that other components within the
Stevia whole leaf extract could have antimicrobial activity against B. burgdorferi, which are yet to be identified in
future studies. In a good agreement with our findings, Stevia leaf extract has also demonstrated antimicrobial activity against pathogens such as E. coli, S. aureus, Vibrio
mimicus, Salmonella typhimurium, S. mutans, Bacillus
subtilis, Shigella dysenteriae, and Vibrio cholera [38–42].
The next question is whether Stevia could be safely used
European Journal of Microbiology and Immunology

as a therapeutic agent. Toxicological studies have shown
that Stevia does not have mutagenic, teratogenic, or carcinogenic effects [57], and recent studies demonstrated
its safety at high dietary intake levels [57–59]. In a study
examining the mutagenicity of Stevioside and Steviol, it
was noted that Stevioside at 10 mg/ml did not induce any
mutation in S. typhimurium [60]. Apart from these studies, there are two important clinical studies based on the
glycoproteins present in Stevia. In a randomized, doubleblinded study on Chinese men and women experiencing
mild hypertension, it was reported that the glycoprotein
stevioside decreased the systolic and diastolic blood pressure and also improved quality of life without causing any
adverse effects compared to the placebo [44]. In another
study, the acute effects of stevioside in type 2 diabetic patients were analyzed [45]. Compared to the control group,
stevioside reduces postprandial blood glucose levels in
type 2 diabetic patients [45]. It was noted that both these
studies used an encapsulated powdered form of stevioside
and whole leaf extract that had been taken orally [44, 45].
It was also observed that one of the clinical studies used a
whole leaf preparation, which contained 91% stevioside,
4% rebaudioside A, and 5% of other derivatives of stevioside [45]. The outcome from these clinical studies demonstrates that the patients did not encounter any adverse
effects from the use of stevioside [44, 45]. Although the
safeness of Stevia is widely studied, more in vivo studies
are warranted before Stevia could be used as an antimicrobial agent for any infectious diseases.
Our future goal is to further investigate the individual components of whole leaf Stevia extract against
B. burgdorferi and to identify the most effective component responsible for its significant antimicrobial effect.
In conclusion, the overall antimicrobial effectiveness of
Stevia A extract on the different morphological forms of
B. burgdorferi was comparable to the combination of certain antibiotics. Although the results of this preliminary
study cannot be extrapolated directly to clinical practice,
further follow-up studies are necessary which can address
the safeness of Stevia and to further identify the most effective component(s) against Borrelia.
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